Over 5,000 expected to attend SNMMI annual meeting in Denver
June 10, 2017
The Society of Nuclear Medicine and Molecular Imaging’s 2017 annual meeting takes place in Denver June 10-14.
It will bring together more than 5,000 physicians, technologists, scientists and exhibitors from around the globe to learn about cutting-edge research and advance their knowledge through continuing education sessions.
The focus is on science, including: improving patients’ lives by creating new equipment or probes to diagnose earlier and more accurately; delivering the most effective therapy for a specific patient’s disease; and how to monitor and adjust treatment to ensure optimum results. There will be tracks for scientists, physicians and technologists, covering the latest advances, including the growing role of nuclear medicine and molecular imaging in precision medicine.
The opening plenary session on Sunday, June 11, will feature theranostics. The Henry N. Wagner, Jr., M.D. Lecture, titled “Theranostics: Looking Back and Moving Forward,” will be given by Richard Baum, M.D., Ph.D. In addition, Johannes Czernin, M.D., editor-in-chief of The Journal of Nuclear Medicine, will speak about “Imaging with a Purpose: The Future of Nuclear Medicine, Molecular Imaging and Therapy.”
The opening plenary will also introduce the society’s new value initiative, which addresses five critical domains that will guide the society’s strategic plan over the next several years: quality of practice; research and development; workforce pipeline and lifetime education; advocacy; and outreach.
SNMMI is an international organization that relies on collaboration across borders. This year, the annual meeting will highlight Germany’s latest advances in research, technology and clinical practice.
Additional meeting highlights include sessions on new tracers and applications, emerging technologies, a fluciclovine live reader training, updates on appropriate use criteria and coding and reimbursement, and Mo-99 production and availability. The exhibit hall will be a one-stop showcase for cutting-edge molecular imaging devices, products and services.
The CT and MRI case reviews, presented in collaboration with the University of Colorado Denver, will provide 12 hours of review over two consecutive days and include 52 CT studies and 48 MRI case studies.
Patient Education Day, June 11, will feature breakout sessions on neuroendocrine tumors, prostate cancer, thyroid cancer and Alzheimer’s disease.